Cargando…
Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures
INTRODUCTION: In donation after circulatory determination of death, death is declared 5 min after circulatory arrest. This practice assumes, but does not explicitly confirm, permanent loss of brain activity. While this assumption is rooted a strong physiological rationale, paucity of direct human da...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152060/ https://www.ncbi.nlm.nih.gov/pubmed/37105694 http://dx.doi.org/10.1136/bmjopen-2023-073643 |
_version_ | 1785035675173650432 |
---|---|
author | Gofton, Teneille Dhanani, Sonny Meade, Maureen Boyd, John Gordon Chamberlain, Erika Chandler, Jennifer Chassé, Michaël Scales, Nathan B Choi, Yun-Hee D'Aragon, Frédérick Debicki, Derek English, Shane Fantaneanu, Tadeu A Kramer, Andreas H Kromm, Julie Murphy, Nicholas Norton, Loretta Singh, Jeffrey Smith, Maxwell J Weijer, Charles Shemie, Sam Bentall, Tracey C Campbell, Eileen Slessarev, Marat |
author_facet | Gofton, Teneille Dhanani, Sonny Meade, Maureen Boyd, John Gordon Chamberlain, Erika Chandler, Jennifer Chassé, Michaël Scales, Nathan B Choi, Yun-Hee D'Aragon, Frédérick Debicki, Derek English, Shane Fantaneanu, Tadeu A Kramer, Andreas H Kromm, Julie Murphy, Nicholas Norton, Loretta Singh, Jeffrey Smith, Maxwell J Weijer, Charles Shemie, Sam Bentall, Tracey C Campbell, Eileen Slessarev, Marat |
author_sort | Gofton, Teneille |
collection | PubMed |
description | INTRODUCTION: In donation after circulatory determination of death, death is declared 5 min after circulatory arrest. This practice assumes, but does not explicitly confirm, permanent loss of brain activity. While this assumption is rooted a strong physiological rationale, paucity of direct human data regarding temporal relationship between cessation of brain activity and circulatory arrest during the dying process threatens public and healthcare provider trust in deceased organ donation. METHODS AND ANALYSIS: In this cohort study, we will prospectively record cerebral and brainstem electrical activity, cerebral blood flow velocity and arterial blood pressure using electroencephalography (EEG), brainstem evoked potentials, transcranial doppler and bedside haemodynamic monitors in adult patients undergoing planned withdrawal of life sustaining measures in the intensive care units at five hospital sites for 18 months. We will use MATLAB to synchronise waveform data and compute the time of cessation of each signal relative to circulatory arrest. Our primary outcome is the feasibility of patient accrual, while secondary outcomes are (a) proportion of patients with complete waveform recordings and data transfer to coordinating site and (b) time difference between cessation of neurophysiological signals and circulatory arrest. We expect to accrue 1 patient/site/month for a total of 90 patients. ETHICS AND DISSEMINATION: We have ethics approval from Clinical Trials Ontario (protocol #3862, version 1.0, date 19 January 2022.) and the relevant Research Ethics Board for each site. We will obtain written informed consent from legal substitute decision makers. We will present study results at research conferences including donor family partner forum and in peer-reviewed publications. TRIAL REGISTRATION NUMBER: NCT05306327. |
format | Online Article Text |
id | pubmed-10152060 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-101520602023-05-03 Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures Gofton, Teneille Dhanani, Sonny Meade, Maureen Boyd, John Gordon Chamberlain, Erika Chandler, Jennifer Chassé, Michaël Scales, Nathan B Choi, Yun-Hee D'Aragon, Frédérick Debicki, Derek English, Shane Fantaneanu, Tadeu A Kramer, Andreas H Kromm, Julie Murphy, Nicholas Norton, Loretta Singh, Jeffrey Smith, Maxwell J Weijer, Charles Shemie, Sam Bentall, Tracey C Campbell, Eileen Slessarev, Marat BMJ Open Intensive Care INTRODUCTION: In donation after circulatory determination of death, death is declared 5 min after circulatory arrest. This practice assumes, but does not explicitly confirm, permanent loss of brain activity. While this assumption is rooted a strong physiological rationale, paucity of direct human data regarding temporal relationship between cessation of brain activity and circulatory arrest during the dying process threatens public and healthcare provider trust in deceased organ donation. METHODS AND ANALYSIS: In this cohort study, we will prospectively record cerebral and brainstem electrical activity, cerebral blood flow velocity and arterial blood pressure using electroencephalography (EEG), brainstem evoked potentials, transcranial doppler and bedside haemodynamic monitors in adult patients undergoing planned withdrawal of life sustaining measures in the intensive care units at five hospital sites for 18 months. We will use MATLAB to synchronise waveform data and compute the time of cessation of each signal relative to circulatory arrest. Our primary outcome is the feasibility of patient accrual, while secondary outcomes are (a) proportion of patients with complete waveform recordings and data transfer to coordinating site and (b) time difference between cessation of neurophysiological signals and circulatory arrest. We expect to accrue 1 patient/site/month for a total of 90 patients. ETHICS AND DISSEMINATION: We have ethics approval from Clinical Trials Ontario (protocol #3862, version 1.0, date 19 January 2022.) and the relevant Research Ethics Board for each site. We will obtain written informed consent from legal substitute decision makers. We will present study results at research conferences including donor family partner forum and in peer-reviewed publications. TRIAL REGISTRATION NUMBER: NCT05306327. BMJ Publishing Group 2023-04-27 /pmc/articles/PMC10152060/ /pubmed/37105694 http://dx.doi.org/10.1136/bmjopen-2023-073643 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Intensive Care Gofton, Teneille Dhanani, Sonny Meade, Maureen Boyd, John Gordon Chamberlain, Erika Chandler, Jennifer Chassé, Michaël Scales, Nathan B Choi, Yun-Hee D'Aragon, Frédérick Debicki, Derek English, Shane Fantaneanu, Tadeu A Kramer, Andreas H Kromm, Julie Murphy, Nicholas Norton, Loretta Singh, Jeffrey Smith, Maxwell J Weijer, Charles Shemie, Sam Bentall, Tracey C Campbell, Eileen Slessarev, Marat Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
title | Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
title_full | Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
title_fullStr | Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
title_full_unstemmed | Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
title_short | Neurologic Physiology after Removal of Therapy (NeuPaRT) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
title_sort | neurologic physiology after removal of therapy (neupart) study: study protocol of a multicentre, prospective, observational, pilot feasibility study of neurophysiology after withdrawal of life-sustaining measures |
topic | Intensive Care |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10152060/ https://www.ncbi.nlm.nih.gov/pubmed/37105694 http://dx.doi.org/10.1136/bmjopen-2023-073643 |
work_keys_str_mv | AT goftonteneille neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT dhananisonny neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT meademaureen neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT boydjohngordon neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT chamberlainerika neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT chandlerjennifer neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT chassemichael neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT scalesnathanb neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT choiyunhee neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT daragonfrederick neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT debickiderek neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT englishshane neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT fantaneanutadeua neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT kramerandreash neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT krommjulie neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT murphynicholas neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT nortonloretta neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT singhjeffrey neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT smithmaxwellj neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT weijercharles neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT shemiesam neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT bentalltraceyc neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT campbelleileen neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures AT slessarevmarat neurologicphysiologyafterremovaloftherapyneupartstudystudyprotocolofamulticentreprospectiveobservationalpilotfeasibilitystudyofneurophysiologyafterwithdrawaloflifesustainingmeasures |